NIH-funded research R01 grant

Understanding coma in cerebral malaria and the brain chemistry behind it

Official title: Defining the mechanism of coma in cerebral malaria

Funded at Albert Einstein College of Medicine · NIH-11377368 · Data updated 2026-11-12

Researchers are studying why some children with cerebral malaria fall into coma, focusing on a brain chemical called pipecolic acid and how it might affect brain activity.

More Malaria research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionAlbert Einstein College of Medicine
NIH-funded
Lab location1 site (Bronx, United States)
Project startJuly 8, 2022
Project endJune 30, 2027
Funding year2026
Award (this year)$529,226
NIH project number5R01AI164864-05
Project IDNIH-11377368 on NIH RePORTER

Who could benefit from this research

Could help

Children with cerebral malaria or other severe malaria presentations, especially those under age 12, in settings where CM is treated.

Less likely to help

Patients without cerebral malaria or those not exposed to the studied parasite models may not benefit directly.

What this research studies

Cerebral malaria can cause coma and has high risks for children. The project looks at pipecolic acid levels in blood and cerebrospinal fluid to see if they are linked to coma in malaria cases. It uses animal models to compare different malaria strains and tests whether pipecolic acid affects brain function through GABA receptors. The study also aims to map how pipecolic acid is made and whether it helps parasites cope with stress.

Why it matters

Potential benefit: If successful, this work could lead to new targets for treatments that prevent or lessen coma in cerebral malaria.

How similar studies have gone: Previous work has linked pipecolic acid to coma in animal models and malaria biology, with some studies suggesting a role in brain function.

Where this research is happening

  • Albert Einstein College of Medicine
    Bronx, United States
    Active

Researchers

  • Principal investigator: Daily, Johanna Patricia — Albert Einstein College of Medicine
  • Study coordinator: Daily, Johanna Patricia

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.